Lv52
1040 积分 2024-02-17 加入
522 Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer
15天前
已完结
The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers
19天前
已完结
The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy
20天前
已完结
Resistance to immune checkpoint inhibitors and the tumor microenvironment
24天前
已完结
Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR -Mutant Lung Cancers
24天前
已完结
Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
24天前
已完结
Cellular plasticity and non-small cell lung cancer: role of T and NK cell immune evasion and acquisition of resistance to immunotherapies
1个月前
已完结
Small Cell Lung Cancer Transformation as a Mechanism of Resistance to PD-1 Therapy in KRAS-Mutant Lung Adenocarcinoma: A Report of Two Cases
1个月前
已完结
Transformation to small cell lung cancer as a mechanism of resistance to immunotherapy in non-small cell lung cancer
1个月前
已完结
Histological transformation into SCLC: An important resistance mechanism of NSCLC upon immunotherapy
1个月前
已完结
皖公网安备34019202002308
